105 related articles for article (PubMed ID: 2830423)
1. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by CD-349, a novel 1,4-dihydropyridine derivative: effect of EGTA on the inhibitory activity.
Tanaka M; Muramatsu M; Aihara H
Jpn J Pharmacol; 1987 Oct; 45(2):203-10. PubMed ID: 2830423
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
4. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
5. Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.
Xiong Y; Westhead EW; Slakey LL
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):627-33. PubMed ID: 7832782
[TBL] [Abstract][Full Text] [Related]
6. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
7. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
10. Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase.
Ronca-Testoni S; Hrelia S; Hakim G; Rossi CA
Experientia; 1985 Jan; 41(1):75-6. PubMed ID: 2981701
[TBL] [Abstract][Full Text] [Related]
11. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
12. Calcium inhibition of a heat-stable cyclic nucleotide phosphodiesterase from Neurospora crassa.
Shaw NM; Harding RW
FEBS Lett; 1983 Feb; 152(2):295-9. PubMed ID: 6298002
[TBL] [Abstract][Full Text] [Related]
13. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N
Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
Itoh H; Hidaka H
J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
[TBL] [Abstract][Full Text] [Related]
16. Multiple forms of cyclic nucleotide phosphodiesterase in a murine adrenal cortex cell line (Y-1).
Ryan JA; Toscano WA
Arch Biochem Biophys; 1985 Sep; 241(2):403-12. PubMed ID: 2994565
[TBL] [Abstract][Full Text] [Related]
17. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
19. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
20. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
